CHRDL2 is highly expressed in osteosarcoma tissues, and it was confirmed experimentally that CHRDL2 promotes the metastasis and proliferation of osteosarcoma cells through the BMP-9/PI3K/AKT pathway (Figure 1B) (86). Here, PIK3CD is linked to osteosarcoma.